Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants
Status:
Completed
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a two-part, open-label, randomized, crossover study in healthy subjects (vasectomized
males and women of non-childbearing potential), performed at 2 study centers